(STRUCTURE AND DRUG SCREENING) In the previous CCSG renewal, Structural Biology (SB) and High-Throughput Screening (HTS) were both approved and funded as new Shared Resources (SRs). During the project period, the independent SRs frequently coordinated services for University of Michigan Comprehensive Cancer Center (UMCCC) members to increase the efficiency and impact of cancer-related projects. This collaboration demonstrated the benefit of working together from project initiation. The SRs and UMCCC leaders viewed the amalgamation of the SR as a natural progression and a way for members to receive maximum benefit from these vital resources. With support from UMCCC Senior Leadership, Janet Smith, PhD was joined by Co-Director Vince Groppi, PhD in 2015 when they formally merged the SRs into one unit. During this process, Medicinal Chemistry (MC) was added to the SR to meet existing needs of cancer researchers. In 2016, UMCCC approved the establishment of a comprehensive unified facility, the Structure and Drug Screening (SDS) SR. The SDS SR enables UMCCC members to use advanced structure-based drug design and/or nonbiased HTS strategies to identify chemical matter that can be advanced through a milestone-driven research plan resulting in efficient and effective discovery and development of precision oncology medicines; a strategic goal of UMCCC. This is accomplished by use of three service disciplines, each of which is guided by an experienced faculty leader: SB, under the direction of Dr. Smith; HTS, under the direction of Dr. Groppi, and MC under the direction of Andrew White, PhD. The SR's cohesive activities, services and processes yield four key benefits to UMCCC members: I) projects are advanced along the translational pipeline, from basic science discoveries into early cancer drug discovery; II) a project manager guides researchers in the effective and efficient use of appropriate services matched to their needs; III) an integrated team approach provides researchers a complete, `one-stop' set of expertise for the duration of their projects; and IV) researchers accrue cost savings from a streamlined administrative support structure.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-30
Application #
9744577
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
30
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Khoriaty, Rami; Hesketh, Geoffrey G; Bernard, Amélie et al. (2018) Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. Proc Natl Acad Sci U S A 115:E7748-E7757
Katz, Steven J; Ward, Kevin C; Hamilton, Ann S et al. (2018) Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. J Clin Oncol 36:1218-1224
Ulintz, Peter J; Greenson, Joel K; Wu, Rong et al. (2018) Lymph Node Metastases in Colon Cancer Are Polyclonal. Clin Cancer Res 24:2214-2224
Qin, Tingting; Zhang, Yanxiao; Zarins, Katie R et al. (2018) Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort. Sci Rep 8:11458
Xu, Shilin; Aguilar, Angelo; Xu, Tianfeng et al. (2018) Design of the First-in-Class, Highly Potent Irreversible Inhibitor Targeting the Menin-MLL Protein-Protein Interaction. Angew Chem Int Ed Engl 57:1601-1605
Crespo, Joel; Wu, Ke; Li, Wei et al. (2018) Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis. J Immunol 201:814-820
Manohar, Poorni M; Beesley, Lauren J; Bellile, Emily L et al. (2018) Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Nucl Med 43:641-647
Hawley, Sarah T; Li, Yun; An, Lawrence C et al. (2018) Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial. J Clin Oncol 36:659-666
Salami, Simpa S; Hovelson, Daniel H; Kaplan, Jeremy B et al. (2018) Transcriptomic heterogeneity in multifocal prostate cancer. JCI Insight 3:
Smith, Joshua; Kulkarni, Aditi; Birkeland, Andrew C et al. (2018) Whole-Exome Sequencing of Sinonasal Small Cell Carcinoma Arising within a Papillary Schneiderian Carcinoma In Situ. Otolaryngol Head Neck Surg 159:859-865

Showing the most recent 10 out of 1493 publications